Ticker: HOWL

Company: Werewolf Therapeutics, Inc.

Person: LUKE EVNIN, director

Transaction date: Jan. 16, 2026

Reporting date: Jan. 20, 2026

Average share price: 0.54

Sold 38782.0 shares for 20942.28